In part 2 of our conversation with Nick Stone, we discuss topics such as machine learning (ML) and spectrometer transferability in clinical settings.
Transferability between spectrometers is a critical challenge for the implementation of advanced diagnostic technologies like Raman spectroscopy in clinical analysis. There have been several studies recently that have explored this topic at length. In one study, a research team from Norway studied a method using partial least squares (PLS) models to assist in transferring calibrations between different Raman and near-infrared (NIR) spectrometers (1).
In clinical analysis, vibrational spectroscopy for analytical measurements has become more popular. The reason for this trend is that spectroscopy not only allows for rapid analysis, but it is also inexpensive (1). These two reasons benefit the patient and the physician, because it helps expedite patient treatment and therefore improve patient outcomes.
Spectrometers, even those of the same make and model, can produce variations in spectral data because of differences in calibration, environmental conditions, and operator expertise (1). Calibration techniques attempt to solve this issue between instruments when data transferability is required. Historically, transferability has involved extensive computational corrections and data pre-processing to align spectra from different instruments, adding layers of complexity and creating barriers to widespread clinical adoption (1,2).
Efforts to improve transferability have focused on developing standardized protocols and calibration techniques to reduce variability between spectrometers (2). Studies like the one led by Dr. Nick Stone have demonstrated that, by adhering to common data acquisition protocols, it is possible to maintain high diagnostic accuracy when transferring Raman spectra across multiple clinical centers (3,4). For instance, Stone’s work in esophageal cancer detection showed no significant drop in model performance or log-loss when applying data from one center to another, despite using spectrometers at different locations (4). Notably, this was achieved without the need for complex computational corrections.
In part two of our conversation with Stone, he discusses these issues and answers the following questions:
To view the rest of our coverage of the upcoming SciX 2024 Conference, click here: https://www.spectroscopyonline.com/conferences/scix
Raman Spectroscopy to Detect Lung Cancer and Monitor Vaccine Effects
January 20th 2025A new study highlights the use of Raman spectroscopy to detect lung cancer and evaluate the effects of the PCV13 vaccine. Researchers found distinct biochemical changes in lung cancer patients and healthy individuals, revealing the vaccine's significant impact on immune response.
An Inside Look at the Fundamentals and Principles of Two-Dimensional Correlation Spectroscopy
January 17th 2025Spectroscopy recently sat down with Isao Noda of the University of Delaware and Young Mee Jung of Kangwon National University to talk about the principles of two-dimensional correlation spectroscopy (2D-COS) and its key applications.
Nanometer-Scale Studies Using Tip Enhanced Raman Spectroscopy
February 8th 2013Volker Deckert, the winner of the 2013 Charles Mann Award, is advancing the use of tip enhanced Raman spectroscopy (TERS) to push the lateral resolution of vibrational spectroscopy well below the Abbe limit, to achieve single-molecule sensitivity. Because the tip can be moved with sub-nanometer precision, structural information with unmatched spatial resolution can be achieved without the need of specific labels.
New SERS-Microfluidic Platform Classifies Leukemia Using Machine Learning
January 14th 2025A combination of surface-enhanced Raman spectroscopy (SERS) and machine learning on microfluidic chips has achieved an impressive 98.6% accuracy in classifying leukemia cell subtypes, offering a fast, highly sensitive tool for clinical diagnosis.
Machine Learning-Enhanced SERS Technology Advances Cancer Detection
January 13th 2025Researchers at the Chinese Academy of Sciences have developed an optical detection strategy for circulating tumor cells (CTCs), combining machine learning (ML) and dual-modal surface-enhanced Raman spectroscopy (SERS). This approach offers high sensitivity, specificity, and efficiency, potentially advancing early cancer diagnosis.